Director of the Medical Imaging Department and Chairman of Radiology at La Fe University and Polytechnic Hospital in Valencia, Spain. He is also founder and director of the Biomedical Imaging Research Group (GIBI230) at La Fe Health Research Institute.
Luis Martí-Bonmatí is the Director of the Medical Imaging Department and Chairman of Radiology at La Fe University and Polytechnic Hospital in Valencia, Spain. He is also founder and director of the Biomedical Imaging Research Group (GIBI230) at La Fe Health Research Institute, hosting both advanced clinical and experimental radiology facilities.
Prof. Martí Bonmatí received his medical degree from the University of Valencia in 1983. He completed his residency in radiology in 1987 and earned his PhD in 1991. He started working in the first university hospital equipped with an MR system in Spain, Dr. Peset University Hospital, where he later became chief of the MRI section. In 2009 he took on his current role at La Fe University and Polytechnic Hospital, which is the reference centre for advanced treatments and complex diseases in the Valencian Community.
That same year, he was designated as radiology coordinator of the Catholic University in Valencia, and two years later became Professor of Radiology at the University of Valencia. To this day, he has supervised 53 doctoral theses and end of career projects.
From 1997 to 2021, Prof. Martí-Bonmatí also headed the Radiology Department at Quirónsalud Hospital Valencia, where he integrated biomedical engineering directly in the reading rooms and the whole radiological innovation process.
His main interests are computational imaging, radiomics and biomarkers, image processing, imaging biobanks and clinical innovations in medical imaging and artificial intelligence. He has authored over 600 publications and his numerous research collaborations continue to facilitate joint efforts between different specialties and significantly improve the development and validation of imaging biomarkers.
He is active in five European initiatives, coordinating the PRIMAGE and CHAIMELEON Horizon 2020 projects, dealing with on medical imaging, artificial intelligence, image repositories and predictive models with observational studies.
Prof. Martí Bonmatí is also co-founder of Quibim, a widely known MedTech company that spun-out from La Fe that mines medical images to extract imaging biomarkers as critical and often evasive health indicators, unveiling the human body to detect disease signatures and monitor biological systems with the highest resolution. His footprint is clearly patent in Quibim’s mission to improve human health through AI-guided precision medicine and apply advanced computational models to boost discoveries and innovations.
He is a full Academic Member of the Spanish Royal National Academy of Medicine, representing radiology, and a member of the Spanish National Radiology Commission, advising the Spanish Ministry of Health in specialty advanced education.
Prof. Martí-Bonmatí has served as president of scientific societies such as the European Society of Magnetic Resonance in Medicine and Biology (ESMRMB), Spanish Society of Radiology (SERAM), Spanish Society of Abdominal Radiology (SEDIA) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR). He is also former president of the SERAM and ESGAR annual meetings and has received the Gold Medal of the SERAM, SEDIA and ESGAR.
Prof. Martí-Bonmatí has been a member of the ESR’s Executive Council in 2010-2013, serving as director of the Research Committee and initiating the Imaging Biomarkers Subcommittee. He represented radiology in the European Council for Health Research at the Alliance for Biomedical Research in Europe. He is now a member of the ESR eHealth and Informatics Subcommittee.
He has received honorary fellowship of the European Society of Medical Imaging Informatics (EuSoMII) and the American College of Radiology (ACR), and more recently the Most Effective Radiology Educator award from Aunt Minnie Europe.
He is now the proud Editor in Chief of Insights into Imaging, achieving a over 5 Impact Factor in the last 2021 and 2022, and positioning the journal in the first quartile (Q1) of the medical imaging journal.
